Clinical characteristics and viral load patterns in children with cytomegalovirus gastrointestinal disease after allogeneic hematopoietic stem cell transplantation

[1]  Jae Wook Lee,et al.  Efficacy of low dose antithymocyte globulin on overall survival, relapse rate, and infectious complications following allogeneic peripheral blood stem cell transplantation for leukemia in children , 2020, Bone Marrow Transplantation.

[2]  J. Kok,et al.  New advances in the management of cytomegalovirus in allogeneic haemopoietic stem cell transplantation , 2020, Internal medicine journal.

[3]  Hee‐Je Kim,et al.  Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy , 2019, International journal of molecular sciences.

[4]  J. Kanda,et al.  Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation , 2018, Bone Marrow Transplantation.

[5]  G. Gutiérrez-García,et al.  Deleterious Effect of Steroids on Cytomegalovirus Infection Rate after Allogeneic Stem Cell Transplantation Depends on Pretransplant Cytomegalovirus Serostatus of Donors and Recipients. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  R. Knobler,et al.  Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment , 2017, American Journal of Clinical Dermatology.

[7]  G. Carcelain,et al.  Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation , 2017, The Journal of infectious diseases.

[8]  J. Lee,et al.  Diagnosis of cytomegalovirus pneumonia by quantitative polymerase chain reaction using bronchial washing fluid from patients with hematologic malignancies , 2017, Oncotarget.

[9]  R. Kanthan,et al.  Cytomegalovirus Colitis: An Uncommon Mimicker of Common Colitides. , 2016, Archives of pathology & laboratory medicine.

[10]  A. Sepulveda,et al.  Histopathology of Graft-vs-Host Disease of Gastrointestinal Tract and Liver:  An Update. , 2016, American journal of clinical pathology.

[11]  M. Sorror,et al.  CMV Viral Load and Mortality after Hematopoietic Cell Transplantation: A Cohort Study in the Era of Preemptive Therapy , 2016, The Lancet. Haematology.

[12]  B. Cho,et al.  Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission , 2016, Oncotarget.

[13]  H. Greinix,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease , 2015 .

[14]  P. Muranski,et al.  The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approaches. , 2014, Cytotherapy.

[15]  S. Lee,et al.  Infectious complications following allogeneic stem cell transplantation: reduced‐intensity vs. myeloablative conditioning regimens , 2013, Transplant infectious disease : an official journal of the Transplantation Society.

[16]  M. Horowitz,et al.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation. , 2012, Blood.

[17]  A. Gratwohl,et al.  Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  Jun Kato,et al.  Cytomegalovirus infection/disease after hematopoietic stem cell transplantation , 2010, International journal of hematology.

[19]  Yonggoo Kim,et al.  Comparison of Quantitative Cytomegalovirus Real-time PCR in Whole Blood and pp65 Antigenemia Assay: Clinical Utility of CMV Real-time PCR in Hematopoietic Stem Cell Transplant Recipients , 2009, Journal of Korean medical science.

[20]  Daniel Wolff,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[21]  G. Papanicolaou,et al.  Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  D. Weisdorf,et al.  Cytomegalovirus enteritis among hematopoietic stem cell transplant recipients. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  G. Schoch,et al.  Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant , 1993, Annals of Internal Medicine.

[24]  J. Meyers,et al.  Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. , 1991, The New England journal of medicine.

[25]  C. V. van Buren,et al.  THE ADVERSE IMPACT OF CYTOMEGALOVIRUS INFECTION ON CLINICAL OUTCOME IN CYCLOSPORINE‐PREDNISONE TREATED RENAL ALLOGRAFT RECIPIENTS , 1988, Transplantation.

[26]  N. Flournoy,et al.  Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. , 1982, Reviews of infectious diseases.

[27]  V. Miller,et al.  Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  D. Porter,et al.  International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[29]  P. Ljungman,et al.  Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. , 2006, Haematologica.

[30]  M. Boccadoro,et al.  Corticosteroids can reverse severe imatinib-induced hepatotoxicity. , 2006, Haematologica.